• Home
  • News
  • Portfolio News
  • Pyramid Biosciences Announces Exclusive Global License of AstraZeneca TRK Program for Dermatology and Inflammatory Diseases

Pyramid Biosciences Announces Exclusive Global License of AstraZeneca TRK Program for Dermatology and Inflammatory Diseases

18Dec

Pyramid Biosciences Announces Exclusive Global License of AstraZeneca TRK Program for Dermatology and Inflammatory Diseases

Portfolio News
Pyramid Biosciences, Inc. (www.pyramidbio.com), a Boston-based biotechnology company developing new therapies focused on the modulation of cell surface receptors today announced it has entered into an exclusive, worldwide licensing agreement with AstraZeneca PLC for the development and commercialization rights to a novel Tropomyosin receptor kinase (TRK) modulator, PBI-100. Read more >>

Share this post

Related Posts

03Oct

Lia Winter’s experience working with the Anderson Center to start Winter Innovations

The Anderson Center is here to help all Vols turn their ideas into a business. Listen to Lia Winter's experience working... read more
20Jun

Myomo, Inc. to Ring NYSE MKT Closing Bell Today

Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that its Chairman... read more
12May

Lions Clubs make a woman’s virtual world a reality

For the first time, Martin has seen a ray of hope for her eyesight. A friend told her about eSight.... read more
21Mar

Brian able to see wife for first time ever

Brian Casey thought he would never see properly again after losing his sight nearly 27 years ago. The former mechanic, who... read more
06Nov

Regroup Mass Notification Becomes NOAA Weather-Ready Nation Ambassador

Regroup Mass Notification, the award-winning provider of emergency and day-to-day mass communication technology, today announced its official recognition as a... read more
18Oct

BioPharm America™ 2017: Platelet BioGenesis generating platelets on demand

Platelets are the bandaids of the bloodstream. Every year more than two million people in the US receive platelet transfusions... read more
18Aug

Pixability Named to Inc. 5000 List of Fastest-Growing Private Companies for Fourth Consecutive Year

Pixability, the leader in digital video advertising optimization and insights, has earned a competitive place on the Inc. 5000 for... read more
29Nov

View from the Hill: Legally blind WKU student thankful for opportunities

On this Thanksgiving, a WKU senior who is legally blind is especially thankful for not one but two additions that... read more
18Jan

Myomo to raise $6M with eyes on Medicare coverage

Myomo announced today that it entered into securities purchase agreements worth approximately $6 million. The company entered into agreements with... read more
09Dec

The essentials list: Actress Elizabeth Banks shares her holiday hosting essentials

One of the busiest people in Hollywood, actress and filmmaker Elizabeth Banks is looking forward to slowing down this holiday... read more